Romidepsin targets multiple survival signaling pathways in malignant T cells
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Romidepsin targets multiple survival signaling pathways in malignant T cells
Authors
Keywords
-
Journal
Blood Cancer Journal
Volume 5, Issue 10, Pages e357-e357
Publisher
Springer Nature
Online
2015-10-16
DOI
10.1038/bcj.2015.83
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Romidepsin in peripheral and cutaneous T-cell lymphoma: mechanistic implications from clinical and correlative data
- (2015) Susan E. Bates et al. BRITISH JOURNAL OF HAEMATOLOGY
- Comparison of the cytotoxicity of cladribine and clofarabine when combined with fludarabine and busulfan in AML cells: Enhancement of cytotoxicity with epigenetic modulators
- (2015) Benigno C. Valdez et al. EXPERIMENTAL HEMATOLOGY
- The TRAF3 adaptor protein drives proliferation of anaplastic large cell lymphoma cells by regulating multiple signaling pathways
- (2014) Israel Muro et al. CELL CYCLE
- Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders
- (2014) Katrina J. Falkenberg et al. NATURE REVIEWS DRUG DISCOVERY
- ER stress-induced cell death mechanisms
- (2013) Renata Sano et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- The Wnt/β-catenin pathway in ovarian cancer: A review
- (2013) Rebecca C. Arend et al. GYNECOLOGIC ONCOLOGY
- Wnt Signaling in Normal and Malignant Hematopoiesis
- (2013) W. Lento et al. Cold Spring Harbor Perspectives in Biology
- Romidepsin (FK228) and its analogs directly inhibit phosphatidylinositol 3-kinase activity and potently induce apoptosis as histone deacetylase/phosphatidylinositol 3-kinase dual inhibitors
- (2012) Ken Saijo et al. CANCER SCIENCE
- The coactivator role of histone deacetylase 3 in IL-1-signaling involves deacetylation of p65 NF-κB
- (2012) Elisabeth Ziesché et al. NUCLEIC ACIDS RESEARCH
- Inhibition of Histone Deacetylase in Cancer Cells Slows Down Replication Forks, Activates Dormant Origins, and Induces DNA Damage
- (2010) Chiara Conti et al. CANCER RESEARCH
- Romidepsin (FK228), a potent histone deacetylase inhibitor, induces apoptosis through the generation of hydrogen peroxide
- (2010) Hideki Mizutani et al. CANCER SCIENCE
- Physiological Roles of Class I HDAC Complex and Histone Demethylase
- (2010) Tomohiro Hayakawa et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Elongator Controls the Migration and Differentiation of Cortical Neurons through Acetylation of α-Tubulin
- (2009) Catherine Creppe et al. CELL
- Cladribine: not just another purine analogue?
- (2009) Stephen Spurgeon et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Role of reactive oxygen species in proapoptotic ability of oncogenic H-Ras to increase human bladder cancer cell susceptibility to histone deacetylase inhibitor for caspase induction
- (2009) Shambhunath Choudhary et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- 5-Aza-2′-deoxycytidine sensitizes busulfan-resistant myeloid leukemia cells by regulating expression of genes involved in cell cycle checkpoint and apoptosis
- (2009) Benigno C. Valdez et al. LEUKEMIA RESEARCH
- Romidepsin (depsipeptide) induced cell cycle arrest, apoptosis and histone hyperacetylation in lung carcinoma cells (A549) are associated with increase in p21 and hypophosphorylated retinoblastoma proteins expression
- (2007) Vinodhkumar Radhakrishnan et al. BIOMEDICINE & PHARMACOTHERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now